AIM
Price
$2.48
Change
+$0.04 (+1.64%)
Updated
Sep 5 closing price
Capitalization
6.72M
SGMT
Price
$7.11
Change
-$0.14 (-1.93%)
Updated
Sep 5 closing price
Capitalization
231.23M
67 days until earnings call
Interact to see
Advertisement

AIM vs SGMT

Header iconAIM vs SGMT Comparison
Open Charts AIM vs SGMTBanner chart's image
AIM ImmunoTech
Price$2.48
Change+$0.04 (+1.64%)
Volume$51.6K
Capitalization6.72M
Sagimet Biosciences
Price$7.11
Change-$0.14 (-1.93%)
Volume$381.82K
Capitalization231.23M
AIM vs SGMT Comparison Chart in %
Loading...
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AIM vs. SGMT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIM is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AIM: $2.48 vs. SGMT: $7.11)
Brand notoriety: AIM and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AIM: 24% vs. SGMT: 56%
Market capitalization -- AIM: $6.72M vs. SGMT: $231.23M
AIM [@Biotechnology] is valued at $6.72M. SGMT’s [@Biotechnology] market capitalization is $231.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AIM’s FA Score shows that 1 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • AIM’s FA Score: 1 green, 4 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than AIM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AIM’s TA Score shows that 4 TA indicator(s) are bullish while SGMT’s TA Score has 4 bullish TA indicator(s).

  • AIM’s TA Score: 4 bullish, 3 bearish.
  • SGMT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AIM is a better buy in the short-term than SGMT.

Price Growth

AIM (@Biotechnology) experienced а +1.22% price change this week, while SGMT (@Biotechnology) price change was -5.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

SGMT is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMT($231M) has a higher market cap than AIM($6.72M). SGMT YTD gains are higher at: 58.000 vs. AIM (-87.475). AIM has higher annual earnings (EBITDA): -15.32M vs. SGMT (-66.89M). SGMT has more cash in the bank: 125M vs. AIM (835K). SGMT has less debt than AIM: SGMT (152K) vs AIM (2.81M). AIM has higher revenues than SGMT: AIM (121K) vs SGMT (0).
AIMSGMTAIM / SGMT
Capitalization6.72M231M3%
EBITDA-15.32M-66.89M23%
Gain YTD-87.47558.000-151%
P/E RatioN/AN/A-
Revenue121K0-
Total Cash835K125M1%
Total Debt2.81M152K1,845%
FUNDAMENTALS RATINGS
AIM: Fundamental Ratings
AIM
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AIMSGMT
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
77%
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTL5.130.15
+3.01%
Algoma Steel Group
GT8.500.08
+0.95%
Goodyear Tire & Rubber Company (The)
SOL1.880.01
+0.53%
Emeren Group Ltd
DT50.000.23
+0.46%
Dynatrace
ENSC2.13-0.01
-0.70%
Ensysce Biosciences

AIM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AIM has been loosely correlated with CVAC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AIM jumps, then CVAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AIM
1D Price
Change %
AIM100%
+1.64%
CVAC - AIM
44%
Loosely correlated
+0.75%
URGN - AIM
39%
Loosely correlated
+0.43%
SGMT - AIM
30%
Poorly correlated
-1.93%
IBIO - AIM
28%
Poorly correlated
+2.92%
MEIP - AIM
24%
Poorly correlated
-0.94%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with TERN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-1.93%
TERN - SGMT
38%
Loosely correlated
+2.27%
OCUL - SGMT
38%
Loosely correlated
+7.09%
CRBU - SGMT
37%
Loosely correlated
+1.08%
VRDN - SGMT
37%
Loosely correlated
+0.43%
XENE - SGMT
35%
Loosely correlated
+1.48%
More